State Street SPDR S&P Biotech ETF
Not enough financial coverage to compute a composite score for XBI. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.ssga.com/us/en/institutional/etfs/state-street-spdr-sp-biotech-etf-xbi
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
- IPO
- 2006
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $8.56B
- Div Yield
- 0.34%
Performance & Tape
- 52W High
- $139.19
- 52W Low
- $78.00
- 50D MA
- $129.76
- 200D MA
- $116.47
- Beta
- 1.09
- Avg Volume
- 9.32M
Get TickerSpark's AI analysis on XBI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our XBI Coverage
We haven't published any research on XBI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XBI Report →